ACTRN12618001952235已完成2 期
Testing efficacy and safety of A-L for falciparum malaria and P-A for falciparum and vivax malaria in Myit KyiNar township, Kachin state and Kyauk Mee township, Northern Shan state
WHO country office0 个研究点目标入组 45 人开始时间: 2018年12月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
Both A-L and P-A are efficacious for treatment of uncomplicated falciparum malaria while P-A is also for vivax malaria
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 6 Years 至 o limit（—）
- 性别
- All
入选标准
- •For Plasmodium falciparum malaria
- •Patients having asexual parasites of Plasmodium falciparum between 1000-100000 per micro-liter in blood
- •Patients having ages of six years and above will be included
- •Patients who do not have signs and symptoms of severe and complicated malaria
- •Patients who do not have known chronic diseases: Tuberculosis, HIV/AIDS, Malignancies
- •Patients who have not anti-malarials in the past 14 days
- •For Plasmodium vivax malaria
- •Patients having asexual parasites of Plasmodium vivax at least 500-50,000 per micro-liter in blood
- •Patients having ages of six years and above will be included
- •Patients who do not have signs and symptoms of severe and complicated malaria
- •Patients who do not have known chronic diseases: Tuberculosis, HIV/AIDS, Malignancies
- •Patients who have not anti-malarials in the past 14 days
- •P-A was studies for both P.falciparum and P..vivax malaria, while A-L was studies only for P. falciparum malaria
排除标准
- •patients having severe and complicated malaria
研究者
相似试验
已完成
不适用
Efficacy and Effectiveness of Combined Therapy for Uncomplicated Malaria Treatment in PeruMalaria FalciparumNCT00164216Centers for Disease Control and Prevention208
已完成
3 期
Study of ACTs Plus Primaquine for Uncomplicated Plasmodium Vivax MalariaVivax MalariaNCT01288820University of Oxford331
已完成
不适用
TES of Artemether-lumefantrine for Pf in the Philippines in 2015Malaria,FalciparumMalaria RecrudescenceNCT05958693Research Institute for Tropical Medicine, Philippines82
已完成
不适用
TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014Falciparum MalariaVivax MalariaMalariaMalaria RecrudescenceNCT04222088Research Institute for Tropical Medicine, Philippines159
已完成
不适用
Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT)Uncomplicated MalariaNCT00868465Radboud University Medical Center600